Cargando…

OR20-05 Generation Of CDH23-mutated Pituitary Neuroendocrine Tumor Organoids From Induced Pluripotent Stem Cells To Model Cushing’s Disease Pathogenesis

Disclosure: J. Chakrabarti: None. S. Mallick: None. J. Churko: None. J. Eschbacher: None. A.S. Little: None. K.C. Yuen: None. Y. Zavros: None. Background: Cushing's disease (CD) is a debilitating disease caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor (PitNET). While m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Jayati, Mallick, Saptarshi, Churko, Jared, Eschbacher, Jennifer, Little, Andrew S, Ji Yuen, Kevin Choong, Zavros, Yana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Neuroendocrinology And Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554281/ http://dx.doi.org/10.1210/jendso/bvad114.1314

Ejemplares similares

RF01 | PMON168 Hedgehog-Induced Somatostatin Receptor Expression is Inhibited by the Activation of the Glucocorticoid Receptor Signaling Pathway in Human Pituitary Adenoma Organoids
por: Zavros, Yana, et al.
Publicado: (2022)

SAT625 The EGF-TBX19-EGFR Positive Feedback Loop Regulates The Expression Of The CD44v9/SLC7A11 Antioxidant System Within Corticotroph Pituitary Neuroendocrine Tumors
por: Chakrabarti, Jayati, et al.
Publicado: (2023)

Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing’s Disease
por: Chakrabarti, Jayati, et al.
Publicado: (2022)

Canine Pituitary Organoids as 3D In Vitro Model for Cushing Disease
por: Sanders, Karin, et al.
Publicado: (2021)

LBMON176 Management, Safety, And Efficacy Of Osilodrostat Treatment In US Patients With Non-pituitary Cushing's Syndrome: Results From The ILLUSTRATE Study
por: Auchus, Richard Joseph, et al.
Publicado: (2022)

THU077 Differences In Clinicopathological Features Of Acidophil Stem Cell Adenomas Compared To Other Subtypes Of Acromegaly: A Retrospective Study
por: Ji Yuen, Kevin Choong, et al.
Publicado: (2023)

SAT-300 Evading Death: Noxa in Cushing’s Disease Pituitary Adenomas
por: Alvarez, Reinier, et al.
Publicado: (2020)

SAT-248 Cushing’s Disease with Two ACTH-Producing Pituitary Tumors
por: Mathai, Christine, et al.
Publicado: (2020)

THU009 Subclinical Cushing’s Syndrome In An ACTH-secreting Pituitary Macroadenoma
por: Akabogu, Nwamaka Gloria, et al.
Publicado: (2023)

MON-405 Cushing's Disease: An Oligosymptomatic Patient with ACTH-Secreting Pituitary Macroadenoma
por: Manrique Franco, Katty, et al.
Publicado: (2019)

SAT-304 Pituitary Stem Cells May Drive Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2020)

Novel Pituitary Organoid Model as Powerful Tool to Unravel Pituitary Stem Cell Biology Across Ages and Disease
por: J Vankelecom, Hugo E, et al.
Publicado: (2021)

Management of Persistent Cushing’s Disease Despite Prior Pituitary Adenoma Resection in a Pregnant Patient
por: Leiter, Amanda, et al.
Publicado: (2021)

THU108 Pituitary Carcinoma Diagnosed After Ten Years Of Smoldering Ectopic Nasopharyngeal Cushing’s
por: Carafone, Lindsay, et al.
Publicado: (2023)

SAT-459 Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary-Thyroid (HPT) Axes in Cushing Syndrome (CS): A Retrospective Cohort Study
por: Shekhar, Skand, et al.
Publicado: (2019)

ODP303 Cushing's Syndrome Due to Ectopic Adrenocorticotropic Hormone-Secreting Metastatic Neuroendocrine Tumor
por: Cipriani, Allison, et al.
Publicado: (2022)

MON-408 Development of Rapidly Progressive Cushing's Disease Following Pituitary Apoplexy Several Years Prior
por: Ortegon Zambrano, Pilar, et al.
Publicado: (2019)

Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison With Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2021)

THU011 Cushing’s Disease Diagnosis Challenge With Standard Pituitary MRI: A Clinical Case Report
por: Kasiri, Elnaz, et al.
Publicado: (2023)

SUN-463 Tumor Shrinkage with Preoperative Relacorilant Therapy in Two Patients with Cushing Disease Due to Pituitary Macroadenomas
por: Terzolo, Massimo, et al.
Publicado: (2019)

SAT-259 Acromegaly by Pituitary Adenoma Associated with ACTH-Independent Cushing Syndrome by Adrenal Carcinoma: Case Report
por: Minuzzi, Ricardo Kunde, et al.
Publicado: (2020)

MON-440 Cyberknife Radiosurgery for Functional and Non-Functional Pituitary Adenomas: Long-Term Single-Center Experience
por: Yuen, Kevin, et al.
Publicado: (2019)

MON-407 Tumor Control after Radiotherapy and Temozolomide in a Cushing's Disease Patient with Giant Aggressive Pituitary Tumor
por: Valente do Couto, Hugo, et al.
Publicado: (2019)

MON-295 Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison with Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2020)

Cushing’s Disease (CD) Due to ACTH-Secreting Pituitary Microadenoma Incidentally Discovered on a Sestamibi Scan for Primary Hyperparathyroidism
por: Mehmood, Hassan, et al.
Publicado: (2021)

THU036 (68)Ga-DOTATOC PET/CT In Localization Of ACTH-producing Pituitary Tumors In Patients With Cushing Disease
por: Kim, Kyungwon
Publicado: (2023)

THU010 A Case Of Cushing(')s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma
por: Gopinath, Chaitra, et al.
Publicado: (2023)

THU012 Incidental Pituitary Adenoma In A Patient With Ectopic ACTH Secreting Cushing Syndrome - A Diagnostic Conundrum
por: Nali, Meenakshi Sinduri, et al.
Publicado: (2023)

Acromegaly in a Young Women With Pituitary Hyperplasia Secondary to a Neuroendocrine Tumor
por: Bano, Gul
Publicado: (2021)

SAT-279 Crooke’s Cell Adenoma- an Aggressive Form of Cushing’s Disease
por: Radovanovic, Natasa, et al.
Publicado: (2020)

PMON123 Diagnostically Challenging Case of Cushing's Syndrome from a Pancreatic Neuroendocrine Tumor Treated with Radiofrequency Ablation
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

PMON104 Sellar Gangliocytoma-Pituitary Neuroendocrine Tumor (PitNET) Presenting As Acromegaly
por: Aurora, John, et al.
Publicado: (2022)

SAT-314 Pituitary and Neuroendocrine Tumors Exhibit Distinct Transcriptomes on Single Cell RNA Sequencing
por: Zhang, Dongyun, et al.
Publicado: (2020)

FRI308 A Rare Case Of Plurimorphous Plurihormonal Pituitary Neuroendocrine Tumor With LH Hypersecretion
por: Jeevananthan, Athavi, et al.
Publicado: (2023)

THU083 Disulfiram Mediated Anti-tumor Effect In Pituitary Neuroendocrine Tumors By Inducing Cuproptosis
por: Huang, Ning, et al.
Publicado: (2023)

THU084 Corticotroph Tumor Type Influences Clinical Presentation In Patients With Nonfunctioning Pituitary Neuroendocrine Tumors
por: Al-Shamkhi, Nasrin, et al.
Publicado: (2023)

SAT-256 The Ever Confusing Cushing’s Work Up: Is It Real? Is It Pseudo Cushing’s’? Or Could It Be Factitious
por: Ghalib, Luma, et al.
Publicado: (2020)

LBMON177 Dosing And Titration Of Osilodrostat In A Real-world Cohort Of US Patients With Endogenous Cushing's Disease: Analysis Of The ILLUSTRATE Study
por: Ioachimescu, Adriana Gabriela, et al.
Publicado: (2022)

MON-287 Expression of Programmed Death-Ligand 1 (PD-L1) in Human Pituitary Neuroendocrine Tumor
por: Suteau, Valentine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qhr0cno2ngpjbqr20srrpus9mi